Abstract View

Author(s): Dr. Sundhararajan R1, L K. Dhivya*2, Mohan. N3, Paul Christober. M4, Surya Prakash. S5, Tamil selvan. P6

Email(s): 1lkdhivya97@gmail.com

Address:

    Mohammed Sathak College of Pharmacy, Chennai, Tamilnadu

Published In:   Volume - 5,      Issue - 2,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5207  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Ethanolic extract of Euphorbia hirta where evaluated for their carbohydrate enzyme inhibition, it is the key indicator for anti-diabetic potential. The inhibitory activity of EEEH against carbohydrate-digesting enzymes was evaluated and compared with the standard drug acarbose. EEEH exhibited moderate α-amylase inhibitory activity, with an IC₅₀ value of 1.16 mg/mL, indicating measurable enzyme suppression. In comparison, acarbose demonstrated significantly stronger inhibition, as reflected by a lower IC₅₀ value of 0.42 mg/mL. The inhibitory activity of EEEH against α-glucosidase was evaluated and compared with the standard drug acarbose. EEEH exhibited moderate α-glucosidase inhibitory activity, with an IC₅₀ value of 1.21 mg/mL, indicating appreciable enzyme suppression. In contrast, acarbose showed stronger inhibitory potential, as evidenced by a lower IC₅₀ value of 0.44 mg/mL.

Cite this article:
Dr. Sundhararajan R, L K. Dhivya*, Mohan. N, Paul Christober. M, Surya Prakash. S, Tamil selvan. Evaluation of In-vitro Anti-diabetic activity in Ethanolic Stem Extract of Euphobia hirta. IJRPAS, February 2026; 5(2): 88-92.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5207


1.Kausar, J.; Muthumani, D.; Hedina, A.; Ramasamy, S.; Anand, V. Review of the phytochemical and

   pharmacological activities of Euphorbia hirta Linn. Pharmacogn. J. 2016, 8, 310–313. [CrossRef]

2. Sharma, M.; Sheliya, M.A.; Begum, R.; Pillai, K.K.; Aeri, V.; Mir, S.R.; Ali, A.; Sharma, M. In vitro

    α-glucosidase and α-amylase inhibition by aqueous, hydroalcoholic, and alcoholic extract of Euphorbia hirta L. Drug Dev. Ther. 2016, 7, 26. [CrossRef]

3.Sharma, N.K.; Dey, S.; Prasad, R. In vitro antioxidant potential evaluation of Euphorbia hirta L.

    Pharmacologyonline 2007, 1, 91–98.

4. Kumar, S.; Malhotra, R.; Kumar, D. Euphorbia hirta: Its chemistry, traditional and medicinal uses,

    and pharmacological activities. Pharmacogn. Rev. 2010, 4, 58–61. [CrossRef]

5. Tran, N.; Tran, M.; Truong, H.; Le, L. Spray-Drying Microencapsulation of High Concentration of Bioactive Compounds Fragments from Euphorbia hirta L. Extract and Their Effect on Diabetes Mellitus. Foods 2020, 9, 881. [CrossRef]

6. McCue P.P and Shetty, K. “Inhibitory effects of rosmarinic acid extracts on porcine pancreatic

    amylase in vitro,” Asia Pacific Journal of Clinical Nutrition, vol. 13, no. 1, pp. 101–106, 2004.

Related Images:



Recent Images



Pharmacological Properties of Amomum subulatum Roxb., a Significant Medicinal Herb
Clinical Trials of Traditional Herbal Medicines in India: Current Scenario and Challenges
Synthesis of Thiourea Derivatives as Bioisosteric Structures of SERMs Pursuant to Virtual Screening
A Narrative Review of the Prevalence, Types, and Contributing Factors of Drug-Related Problems in Hospitals.
A Review on Nature’s Neglected Treasures Unveiling Medicinal Use of Common Weeds in Drug Therapy: A Statistical Survey
Implantable Drug Delivery Systems: A Comprehensive Review with Recent Advancements
Beyond Diarrhea Control: Emerging Neuroimmune and Psychobiotic Roles of Bacillus clausii
Artificial Intelligence-Enabled Quality by Design and Regulatory Science for Apixaban Orodispersible Tablets: A Critical Review of Clinical Rationale, Formulation Strategy, and Submission-Ready Documentation for Stroke Prevention
Analysis of pro inflammatory cytokinse response among hepatitis B patients co-infected with Plasmodium falciparum in Khartoum state, Sudan
Dual Incretin Agonism in Type 2 Diabetes and Obesity: Systematic Review of Tirzepatide Mechanisms and Clinical Outcomes

Tags